These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23548579)

  • 1. Genetic mutations in patients with acute myeloid leukemia and leukostasis.
    De Santis GC; Benicio MT; Oliveira LC; Falcão RP; Rego EM
    Acta Haematol; 2013; 130(2):95-7. PubMed ID: 23548579
    [No Abstract]   [Full Text] [Related]  

  • 2. Images in clinical medicine. FLT3 Mutation and acute myelogenous leukemia with leukostasis.
    Thornton KA; Levis M
    N Engl J Med; 2007 Oct; 357(16):1639. PubMed ID: 17942876
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular mutations are prognostically relevant in AML with intermediate risk cytogenetics and aberrant karyotype.
    Bacher U; Haferlach T; Alpermann T; Kern W; Schnittger S; Haferlach C
    Leukemia; 2013 Feb; 27(2):496-500. PubMed ID: 22858909
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD.
    Chien W; Sun QY; Ding LW; Mayakonda A; Takao S; Liu L; Lim SL; Tan KT; Garg M; De Sousa Maria Varela A; Xiao J; Jacob N; Behrens K; Stocking C; Lill M; Madan V; Hattori N; Gery S; Ogawa S; Wakita S; Ikezoe T; Shih LY; Alpermann T; Haferlach T; Yang H; Koeffler HP
    Leukemia; 2017 Mar; 31(3):762-766. PubMed ID: 27881871
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML.
    Dicker F; Haferlach C; Sundermann J; Wendland N; Weiss T; Kern W; Haferlach T; Schnittger S
    Leukemia; 2010 Aug; 24(8):1528-32. PubMed ID: 20520634
    [No Abstract]   [Full Text] [Related]  

  • 6. FLT3
    Hyrenius-Wittsten A; Pilheden M; Falqués-Costa A; Eriksson M; Sturesson H; Schneider P; Wander P; Garcia-Ruiz C; Liu J; Ågerstam H; Hultquist A; Lilljebjörn H; Stam RW; Järås M; Hagström-Andersson AK
    Leukemia; 2019 Sep; 33(9):2310-2314. PubMed ID: 30953031
    [No Abstract]   [Full Text] [Related]  

  • 7. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
    Nasilowska-Adamska B; Solarska I; Paluszewska M; Malinowska I; Jedrzejczak WW; Warzocha K
    Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.
    Dufour A; Schneider F; Metzeler KH; Hoster E; Schneider S; Zellmeier E; Benthaus T; Sauerland MC; Berdel WE; Büchner T; Wörmann B; Braess J; Hiddemann W; Bohlander SK; Spiekermann K
    J Clin Oncol; 2010 Feb; 28(4):570-7. PubMed ID: 20038735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia.
    Chowdhury M; Mihara K; Yasunaga S; Ohtaki M; Takihara Y; Kimura A
    Leukemia; 2007 May; 21(5):1116-22. PubMed ID: 17377594
    [No Abstract]   [Full Text] [Related]  

  • 10. "Cup-like" blasts and NPM1 and FLT3 (ITD) mutations in acute myeloid leukemia (AML).
    Jain P; Vega-Vazquez F; Faderl S
    Int J Hematol; 2013 Jul; 98(1):3. PubMed ID: 23690292
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size.
    Nomdedeu J; Bussaglia E; Villamor N; Martinez C; Esteve J; Tormo M; Estivill C; Queipo MP; Guardia R; Carricondo M; Hoyos M; Llorente A; Juncà J; Gallart M; Domingo A; Bargay J; Mascaró M; Moraleda JM; Florensa L; Ribera JM; Gallardo D; Brunet S; Aventin A; Sierra J;
    Leuk Res; 2011 Feb; 35(2):163-8. PubMed ID: 20542566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.
    Damm F; Heuser M; Morgan M; Yun H; Grosshennig A; Göhring G; Schlegelberger B; Döhner K; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar A; Fiedler W; Kirchner H; Döhner H; Heil G; Ganser A; Krauter J
    J Clin Oncol; 2010 Feb; 28(4):578-85. PubMed ID: 20038731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemia.
    Yamato G; Yamaguchi H; Handa H; Shiba N; Kawamura M; Wakita S; Inokuchi K; Hara Y; Ohki K; Okubo J; Park MJ; Sotomatsu M; Arakawa H; Hayashi Y
    Genes Chromosomes Cancer; 2017 Nov; 56(11):800-809. PubMed ID: 28710806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia.
    Lapillonne H; Llopis L; Auvrignon A; Renneville A; Labopin M; Mazingue F; Perot C; Lai JL; Philippe N; Ballerini P; Zurawski V; Adam M; Douay L; Leverger G; Landman-Parker J; Preudhomme C
    Leukemia; 2010 Jan; 24(1):205-9. PubMed ID: 19759559
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correlation of Fms-like tyrosine kinase 3 (FLT3) gene expression to FLT3/internal tandem duplication mutation in peripheral blood of acute myeloid leukemia.].
    Xu B; Shi PC; Song XY; Tang JH; Zhou SY
    Ai Zheng; 2009 Jun; 28(6):632-6. PubMed ID: 19635202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2.
    Eisfeld AK; Kohlschmidt J; Mrózek K; Blachly JS; Nicolet D; Kroll K; Orwick S; Carroll AJ; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
    Leukemia; 2016 Nov; 30(11):2254-2258. PubMed ID: 27435003
    [No Abstract]   [Full Text] [Related]  

  • 17. 11q23 rearrangement and duplication of MLLT1-MLL gene fusion in therapy-related acute myeloid leukemia.
    Chin LK; Cheah CY; Michael PM; MacKinnon RN; Campbell LJ
    Leuk Lymphoma; 2012 Oct; 53(10):2066-8. PubMed ID: 22335556
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute myeloid leukemia with normal cytogenetics.
    Mawad R; Estey EH
    Curr Oncol Rep; 2012 Oct; 14(5):359-68. PubMed ID: 22806102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trisomy 11 in myeloid malignancies is associated with internal tandem duplication of both MLL and FLT3 genes.
    Rege-Cambrin G; Giugliano E; Michaux L; Stul M; Scaravaglio P; Serra A; Saglio G; Hagemeijer A
    Haematologica; 2005 Feb; 90(2):262-4. PubMed ID: 15710585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cup-like Blasts in 2 Pediatric Patients With NPM-1-Positive Acute Myeloid Leukemia.
    Tüfekçi Ö; Erdem M; Ören H; Yilmaz Ş
    J Pediatr Hematol Oncol; 2018 May; 40(4):e237-e238. PubMed ID: 29432313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.